BCR-ABL kinase domain mutations in CML patients, experience from a tertiary care center in North India

Simple item page
dc.contributor.authorS A.
dc.contributor.authorshah A.
dc.contributor.authorAshish A.
dc.contributor.authorkumar Singh N.
dc.contributor.authorKaur M.
dc.contributor.authorkumar Yadav A.
dc.contributor.authorsingh R.
dc.date.accessioned2025-01-13T07:09:19Z
dc.date.available2025-01-13T07:09:19Z
dc.date.issued2024
dc.description.abstractBackground: Chronic Myeloid Leukemia is characterized by the presence of the Philadelphia Chromosome (Ph) which contains the BCR
dc.identifier.doi10.1016/j.lrr.2023.100403
dc.identifier.issn22130489
dc.identifier.urihttps://dl.bhu.ac.in/ir/handle/123456789/3643
dc.language.isoen
dc.publisherElsevier Ltd
dc.subjectBCR
dc.subjectChronic myeloid leukemia
dc.subjectImatinib
dc.subjectPhiladelphia chromosome
dc.subjectSanger's sequencing
dc.titleBCR-ABL kinase domain mutations in CML patients, experience from a tertiary care center in North India
dc.typeArticle
journal.titleLeukemia Research Reports
journalvolume.identifier.volume21

Files

Collections

2024